TNFSF10 and neoplasm: Thus, our study has unveiled a novel therapeutic opportunity by disrupting integrin α3-mediated ER homeostasis, which primes tumor cells for apoptosis via the death receptor extrinsic signaling pathway and resensitizes them to TRAIL-mediated cell death.